Migraine is defined by the World Health Organization as one of the chronic diseases of disability, generally manifested as vascular throbbing and swelling pain, accompanied by nausea and vomiting, fear of light and noise, hallucinations, blind spots, blurred vision and other symptoms. According to statistics, people who commit suicide because of chronic migraine are 4-6 times more likely than normal people, and long-term migraine also increases the probability of various complications, among which, the risk of ischemic stroke is 2.16 times higher than normal people, and the risk of brain white matter abnormalities is 3.9 times higher, so migraine is a potential risk factor. Etiology of migraine: As a chronic progressive disease, migraine is formed mainly due to the compression of nerves by blood vessels, in addition to poor dietary and lifestyle habits that may also trigger the occurrence of migraine. In general, the effect of chronic neuropathic migraine is not ideal, so other methods of treatment must be considered. Microvascular decompression for migraine: Microvascular decompression is a minimally invasive procedure for the treatment of neurological migraine without craniotomy, which can be performed under a microscope to find the pressure points of the blood vessels and nerves and separate them. Since its clinical application, microvascular decompression has achieved great success and good results, and is widely recognized and praised by patients.